What's better for weight loss, Mounjaro or Ozempic? New study provides answer
The study found that patients without diabetes lost more weight than patients with diabetes. According to the study's authors, more research is needed to understand why Mounjaro, with the active ingredient tirzepatide, was found to be more effective for weight loss.
Ozempic v. Mounjaro? There's a clear winner for weight loss, study finds.
At the time, tirzepatide hadn't yet been approved for weight loss, just diabetes, so the study looked only at people who had prescriptions for the two drugs for type 2 diabetes, although not everyone had the disease. By November of last year, more than ...
Mounjaro bests Ozempic for weight loss in first head-to-head comparison of real-world use
In the first head-to-head comparison of two blockbuster drugs, patients taking Mounjaro lost more weight than those taking Ozempic.
Ozempic Risks for Weight Loss: Understanding Potential Side Effects
Ozempic, a brand name for the medication semaglutide, has been widely discussed in the context of managing type 2 diab
Mounjaro leads to significantly more weight loss than Ozempic, study suggests
People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study.
Mounjaro Bests Ozempic for Weight Loss
Mounjaro outperforms Ozempic in helping people lose weight, a new study shows. People taking tirzepatide (Mounjaro, Zepbound) dropped significantly more pounds than those taking semaglutide (Ozempic,
Ozempic study: Weight loss more likely with certain drugs than others
Some weight-loss drugs produce better outcomes than others, a study published Monday in JAMA Internal Medicine found. Why it matters: The study confirmed that patients on Mounjaro, a drug approved for diabetes treatment,
Ozempic vs. Mounjaro: New study reveals which is better to combat obesity
Researchers didn't notice major differences in gastrointestinal troubles — like incidences of stomach virus and swelling of the pancreas — between the Mounjaro and Ozempic groups.
Study finds patients lost more weight on Mounjaro than Ozempic
Mounjaro lost significantly more weight than those taking Novo Nordisk’s (NVO) Ozempic. The study, which analyzed the electronic health records of roughly 41,000 obese or overweight patients who took the drugs,
verywellhealth on MSN7h
When Weight Loss Medications May Be a Good Fit for You
Obesity is a chronic disease that often requires medication management and lifestyle medication. See whether weight loss ...
New weight-loss and diabetes drugs linked to lower risk of 10 cancers
For patients with Type 2 diabetes, taking one of the new GLP-1 drugs, such as Ozempic, is associated with lower risks of ...
23 Affordable Ways Frugal People Lose Weight
The weight loss process can be a notoriously expensive affair. But if done right, you can get rid of those extra pounds ...
Experts weigh in on new generation of weight loss medications
We've all seen the ads and read about celebrities who have successfully lost weight using one of the new weight loss ...
Dr. Sanjay Gupta On Call: What are your questions about weight loss drugs?
A new class of medications called glucagon-like peptide 1 receptor agonists, or GLP-1s, have surged in popularity by making ...
CNET on MSN7h
Is There a Connection Between Weight-Loss Drugs and Vision Loss?
Taking semaglutide for weight loss and diabetes, which sells under popular brand names Ozempic and Wegovy, may be linked to ...
verywellhealth on MSN1d
Ask the Expert: Tips for Starting Your Weight Loss Journey
Discover expert advice on starting your weight loss journey, including setting realistic goals, making it personal, and ...
Familial endocrine diseases linked to increased risk of pregnancy loss, new research shows
Women who have close family members with endocrine diseases--including type 2 diabetes, thyroid diseases and polycystic ovary ...